Onco-NX
Salford
About Onco-NX
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $79.6K
- Funding stage: M&A
- Last round: Pre-Seed (Nov 2011)
- Website: onco-nx.com
Industries & Categories
Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/onco-nx-1888076 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.